Stay updated on Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.

Latest updates to the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page
- Check2 days agoChange Detected- The history now shows Revision: v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedAdded Revision: v3.4.2; removed the prior funding-status notice (v3.4.1).SummaryDifference0.5%

- Check38 days agoChange DetectedTwo minor changes are shown: a site-wide notice about government funding status and a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check45 days agoChange DetectedAdds a glossary toggle, color-coded additions/deletions, and a revision label, and removes the older No FEAR Act data line.SummaryDifference0.6%

- Check59 days agoChange DetectedNew revision entry v3.3.4 has been added to the history and the previous entry v3.3.3 has been removed from the log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedThe history page was updated with a new release note Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2, reflecting minor maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.